Lilly Korea said its moderate-to-severe atopic dermatitis treatment Ebglyss (lebrikizumab), an interleukin-13 inhibitor, received approval from the Min...
Trusted Tablets is perceived as one of Mvsvets's biggest rivals. Trusted Tablets's headquarters is in Larnaca, Larnarca District, and was founded in 2007. Like Mvsvets, Trusted Tablets also competes in the Professional Services industry. Trusted Tablets generates 21% of Mvsvets's revenue.